| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| thioredoxin reductase | 4 | 0 | 0 | 4 |
| TDP1 protein | 15 | 0 | 0 | 15 |
| Microtubule-associated protein tau | 8 | 0 | 0 | 9 |
| Smad3 | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 12 | 0 | 0 | 12 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 5 | 0 | 0 | 5 |
| DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| AR protein | 32 | 0 | 0 | 32 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 22 | 0 | 0 | 22 |
| retinoid X nuclear receptor alpha | 23 | 0 | 0 | 23 |
| estrogen nuclear receptor alpha | 32 | 0 | 0 | 32 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| IDH1 | 3 | 0 | 0 | 3 |
| Histone H2A.x | 12 | 0 | 0 | 12 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| mitogen-activated protein kinase 1 | 9 | 0 | 0 | 9 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 2 | 2 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 2 | 7 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Glutamate receptor 2 | 13 | 0 | 0 | 13 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 1 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 3 | 2 | 6 |
| Adenosine receptor A2b | 0 | 0 | 1 | 2 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 2 | 3 | 6 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Adenylate kinase isoenzyme 1 | 0 | 2 | 0 | 3 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| RAR-related orphan receptor gamma | 25 | 0 | 0 | 25 |
| estrogen-related nuclear receptor alpha | 30 | 0 | 0 | 30 |
| euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 20 | 0 | 0 | 20 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 1 | 2 |
| Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| 2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 4 | 0 | 4 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 0 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
| P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
| Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
| Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
| Protease | 0 | 2 | 1 | 3 |
| P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 2 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 15 | 0 | 0 | 15 |
| GLI family zinc finger 3 | 18 | 0 | 0 | 18 |
| nuclear receptor subfamily 1, group I, member 3 | 23 | 0 | 0 | 23 |
| progesterone receptor | 24 | 0 | 0 | 24 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 19 | 0 | 0 | 19 |
| retinoic acid nuclear receptor alpha variant 1 | 26 | 0 | 0 | 26 |
| farnesoid X nuclear receptor | 21 | 0 | 0 | 21 |
| pregnane X nuclear receptor | 31 | 0 | 0 | 31 |
| cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
| peroxisome proliferator activated receptor gamma | 18 | 0 | 0 | 18 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 19 | 0 | 0 | 19 |
| aryl hydrocarbon receptor | 20 | 0 | 0 | 20 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 16 | 0 | 0 | 16 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 20 | 0 | 0 | 20 |
| thyroid hormone receptor beta isoform a | 11 | 0 | 0 | 11 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 23 | 0 | 0 | 23 |
| heat shock protein beta-1 | 18 | 0 | 0 | 18 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 27 | 0 | 0 | 27 |
| geminin | 12 | 0 | 0 | 12 |
| cytochrome P450 3A4 isoform 1 | 9 | 0 | 0 | 9 |
| lamin isoform A-delta10 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit pi | 9 | 0 | 0 | 9 |
| Cellular tumor antigen p53 | 22 | 0 | 0 | 22 |
| Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit delta | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 9 | 0 | 0 | 9 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| GABA theta subunit | 9 | 0 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit epsilon | 9 | 0 | 0 | 9 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
| Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 5 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Bile salt export pump | 0 | 7 | 0 | 7 |
| Beta-lactamase SHV-1 | 0 | 1 | 0 | 2 |
| Beta-lactamase SHV-1 | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
| acetylcholinesterase | 12 | 0 | 0 | 12 |
| peroxisome proliferator-activated receptor delta | 15 | 0 | 0 | 15 |
| serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| estrogen receptor 2 (ER beta) | 16 | 0 | 0 | 16 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| kallikrein-5 preproprotein | 0 | 1 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Interferon beta | 17 | 0 | 0 | 17 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Luciferase | 8 | 0 | 0 | 8 |
| ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
| Ataxin-2 | 6 | 0 | 0 | 6 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| PAX8 | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| pregnane X receptor | 10 | 0 | 0 | 10 |
| phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 10 | 0 | 0 | 10 |
| USP1 protein, partial | 11 | 0 | 0 | 11 |
| SMAD family member 3 | 10 | 0 | 0 | 10 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| PINK1 | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| G | 13 | 0 | 0 | 13 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 4 | 0 | 0 | 4 |
| Parkin | 2 | 0 | 0 | 2 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| caspase-3 | 3 | 0 | 0 | 3 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| thyroid stimulating hormone receptor | 18 | 0 | 0 | 18 |
| activating transcription factor 6 | 11 | 0 | 0 | 11 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 5 | 0 | 0 | 5 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 13 | 0 | 0 | 13 |
| Integrin beta-3 | 3 | 0 | 0 | 3 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
| Spike glycoprotein | 6 | 0 | 0 | 6 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 13 | 0 | 0 | 13 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 13 | 0 | 0 | 13 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| Caspase-7 | 5 | 0 | 0 | 5 |
| serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 5 | 0 | 0 | 5 |
| caspase-3 | 5 | 0 | 0 | 5 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| ORF73 | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| Beta-lactamase OXA-1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| Beta-lactamase TEM | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Class D beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 2 | 0 | 2 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 6 | 0 | 6 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
| alpha synuclein, partial | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 3 | 0 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 2 | 0 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 1 | 3 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| Progesterone receptor | 0 | 2 | 1 | 4 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| GLS protein | 1 | 0 | 0 | 1 |
| Valosin-containing protein | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 2 | 0 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 8 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |